Navigation Links
ViroPharma Announces Completion of Enrollment in Phase 3 Study of Maribavir in Stem Cell Transplant Patients
Date:5/29/2008

- Phase 3 Study in 681 Stem Cell Transplant Patients Represents First Pivotal Study on a New Antiviral CMV Therapy in Stem Cell Transplant in

Over a Decade - - Company Also Provides Timing of Phase 3 Data Disclosure and Regulatory

Submissions -

EXTON, Pa., May 29 /PRNewswire-FirstCall/ -- ViroPharma Incorporated (Nasdaq: VPHM) today announced that it completed enrollment in its pivotal Phase 3 study of maribavir in stem cell transplant patients. This international Phase 3 study is evaluating the efficacy, safety and tolerability of prophylactic use of maribavir administered orally for up to 12 weeks for the prevention of cytomegalovirus (CMV) disease in recipients of allogeneic stem cell transplants (SCT). The study also will evaluate the pharmacokinetics of maribavir in this subject population. It is being conducted in 90 transplant centers in the U.S., Canada, and Europe.

"Maribavir may mark the first new advancement in CMV therapeutics for transplant recipients in many years," stated Stephen Villano, M.D., vice president, clinical research and development at ViroPharma. "CMV can cause significant and potentially deadly clinical manifestations among transplant recipients, and maribavir represents the opportunity for a shift in CMV treatment paradigm toward prophylaxis against CMV, thus preventing CMV viral infection and disease and allowing for enhanced focus on other aspects of patient outcome following transplantation."

The company also provided the timing of future milestones in the development of maribavir in SCT. These include:

-- Data collection for the 6-month assessments will continue through the

end of November 2008;<
'/>"/>

SOURCE ViroPharma Incorporated
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine technology :

1. ViroPharma Announces Discontinuation of HCV-796 Development
2. ViroPharma to Release 2008 First Quarter Financial Results on April 30, 2008
3. ViroPharma To Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
4. ViroPharma to Present at the Natixis Bleichroeder Conference
5. ViroPharma to Present at Three Upcoming Healthcare Conferences
6. Strativa Pharmaceuticals Announces Preliminary Results from ONCONASE(R) Phase IIIb Clinical Trial
7. InterMune Announces Start of 14-Day Triple Combination Study of ITMN-191 in Patients With Chronic Hepatitis C
8. GlaxoSmithKline Announces New Drug Application and Phase III Results for Rezonic(TM)/Zunrisa(TM) (Casopitant)
9. Genmab Announces Updates on Phase III Cancer Studies
10. Kiadis Pharma Announces Collaboration With the Julius Maximilians University of Wurzburg, Germany
11. Alfacell Corporation Announces Preliminary Results From ONCONASE(R) Phase IIIb Clinical Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... IRVINE, Calif. , May 23, 2013 ... breast cancer may not benefit from chemotherapy and still ... announced the launch of one of the largest sources ... The new website and interactive Facebook page provide recently ... if they can safely avoid chemotherapy. "We ...
(Date:5/23/2013)... ARBOR, Mich. , May 23, 2013  Every day, ... flow of air to his lungs. April and ... the dire predictions weren,t true. "Quite a few ... the hospital alive," says April Gionfriddo , ... were desperate. Anything that would work, we would take it ...
(Date:5/23/2013)... Mass. , May 23, 2013  Spring Bank ... the treatment of viral infections, today announced that it ... SB 9200, its investigational, once daily, oral therapy for ... in healthy, HCV-infected patients and is designed to assess ... SB 9200 is a first-in-class drug for the treatment ...
Breaking Medicine Technology:Agendia Launches Social Media Campaigns to Help Breast Cancer Patients with Chemotherapy Decisions 2Agendia Launches Social Media Campaigns to Help Breast Cancer Patients with Chemotherapy Decisions 3Baby's life saved with groundbreaking 3D printed device from U-M that restored his breathing 2Baby's life saved with groundbreaking 3D printed device from U-M that restored his breathing 3Baby's life saved with groundbreaking 3D printed device from U-M that restored his breathing 4Spring Bank Pharmaceuticals Initiates a Phase I Clinical Trial for SB 9200 in HCV-infected Patients 2Spring Bank Pharmaceuticals Initiates a Phase I Clinical Trial for SB 9200 in HCV-infected Patients 3
... Sept. 26 Threshold,Pharmaceuticals, Inc. (Nasdaq: THLD ... trial of glufosfamide plus gemcitabine were presented at ... Spain. In the Phase 2 clinical trial ... of advanced pancreatic cancer, six-month and,one-year survival were ...
... Isis,Pharmaceuticals, Inc. (Nasdaq: ISIS ) announced ... (Ibis), has been awarded a subcontract,of a National ... influenza,surveillance research through application of the Ibis T5000(TM) ... Ibis and the Lovelace,Respiratory Research Institute (LRRI) and ...
Cached Medicine Technology:Positive Glufosfamide Results From a Phase 2 Clinical Trial Presented at European Cancer Conference (ECCO) 2Positive Glufosfamide Results From a Phase 2 Clinical Trial Presented at European Cancer Conference (ECCO) 3Positive Glufosfamide Results From a Phase 2 Clinical Trial Presented at European Cancer Conference (ECCO) 4Isis Announces $1.2 Million Award to Its Ibis Subsidiary to Expand Influenza Detection Capabilities and Enable Large-Scale Influenza Transmission Studies 2Isis Announces $1.2 Million Award to Its Ibis Subsidiary to Expand Influenza Detection Capabilities and Enable Large-Scale Influenza Transmission Studies 3Isis Announces $1.2 Million Award to Its Ibis Subsidiary to Expand Influenza Detection Capabilities and Enable Large-Scale Influenza Transmission Studies 4Isis Announces $1.2 Million Award to Its Ibis Subsidiary to Expand Influenza Detection Capabilities and Enable Large-Scale Influenza Transmission Studies 5
(Date:5/24/2013)... 2013 Chronic Fatigue Syndrome has been ... with unexplained fatigue lasting 6 months or longer. Symptoms ... and concentration impairment, muscle and joint pain without swelling ... sleep and malaise that lasts for more than 24 ... to be linked to insulin resistance. At a healthy ...
(Date:5/24/2013)... May 24, 2013 DiaperBuys.com is pleased ... Photo Contest. Lindsey Willis of Olathe, Kansas, won the ... from DiaperBuys. Second prize was a three-month supply of ... Las Vegas, Nev.; and third prize, a one-month supply, ... contest was run through the company’s Facebook page. Entrants ...
(Date:5/24/2013)... 2013 Scott Ryan Tischler of Tischler ... lose 200 lbs. of fat in just over a ... younger brother the importance of exercising. Scott also taught ... to these 7 rules of healthy eating and having ... be accomplished. , 1.    Find a distraction when a food ...
(Date:5/23/2013)... Over the past decade, the traditional ... has affected the Medical Group Practice Management industry ... hours, more young physicians are opting out of private ... says IBISWorld industry analyst Anna Son. In addition, “faced ... of older physicians are selling their practices and moving ...
(Date:5/23/2013)... Whether working in an urban setting or a ... an added layer of protection at night. The ... is an effective portable, rugged, rapidly deployable wireless infrared ... and perimeter security. , Today, ARA announces that government ... the past three years, with most systems deployed within ...
Breaking Medicine News(10 mins):Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announces New hCG Diet Plans to Promote Fast Weight Loss Shown to Reduce the Risk & Symptoms of Chronic Fatigue 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announces New hCG Diet Plans to Promote Fast Weight Loss Shown to Reduce the Risk & Symptoms of Chronic Fatigue 3Health News:DiaperBuys.com Announces Photo Contest Winners 2Health News:Medical Group Practice Management in the US Industry Market Research Report Now Available from IBISWorld 2Health News:Medical Group Practice Management in the US Industry Market Research Report Now Available from IBISWorld 3Health News:Lighting Up the Night: ARA Announces Record Sales of Its Night VISER System 2Health News:Lighting Up the Night: ARA Announces Record Sales of Its Night VISER System 3
... a prestigious international healthcare and wellness center, will implement the ... Cypress Communications®. , ... Atlanta, GA ... healthcare and wellness center, will implement the C4 IP™ ...
... resident M. Michael Wolfe, MD, chief of the Gastroenterology ... research professor of physiology and biophysics at Boston University ... Top Doctors by Castle Connolly Medical Ltd. , The ... medical care, is a trusted and authoritative resource for ...
... been diagnosed with panic attacks or panic disorder have ... suffering a heart attack than the normal population, with ... published in Europe,s leading cardiology journal, the European ... , The study found that people who were younger ...
... WASHINGTON -- The U.S. Environmental Protection Agency should examine ... cause adverse health effects in humans, says a new ... this analysis, called a cumulative risk assessment, should consider ... effects as phthalates, instead of focusing on chemicals that ...
... prescribed for men with chronic prostatitis, a painful disorder ... significantly reduce symptoms in recently diagnosed men who had ... a clinical trial sponsored by the National Institute of ... the National Institutes of Health (NIH). The study is ...
... people know that how we live our lives effects our ... a healthy lifestyle? Why do health professionals like doctors ... public policy, health services, schools and education, the workplace, the ... support healthier living? For instance, can exercise help with addiction? ...
Cached Medicine News:Health News:MALO CLINIC Avoids Capital Expense and Gains Scalability with Hosted Unified Communications 2Health News:MALO CLINIC Avoids Capital Expense and Gains Scalability with Hosted Unified Communications 3Health News:MALO CLINIC Avoids Capital Expense and Gains Scalability with Hosted Unified Communications 4Health News:Boston University Medical Center gastroenterologist 2Health News:Panic attacks linked to higher risk of heart attacks and heart disease, especially in younger people 2Health News:Panic attacks linked to higher risk of heart attacks and heart disease, especially in younger people 3Health News:EPA should pursue cumulative risk assessment of phthalates and other chemicals 2Health News:EPA should pursue cumulative risk assessment of phthalates and other chemicals 3Health News:Common treatment for chronic prostatitis fails to reduce symptoms 2Health News:New Year starts with focus on healthy living 2Health News:New Year starts with focus on healthy living 3
... Vision® Plus DR Urology System provides a ... the first dedicated digital urology imaging system ... was designed to use optimized geometry and ... intensifier for maximum anatomical coverage and sharper ...
Drew Scientific has been making leading edge, top quality CBC systems for over 15 years.,The Evolution offers all the features of the Excell 16 with the new addition of primary sample tube cap pier...
... ETS™ is a therapeutic, expandable turning surface ... ,INDICATIONS , Prevention and treatment of ... to turn, Large patients using a statuc ... relief surface, Patients whose body weight and ...
... The Maxxis™ 400 is a bariatric ... safety for individuals in the home care ... 1000 lbs. (or combined weight of 2) ... depending on frame size selected , ...
Medicine Products: